Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation
BMC Cardiovascular Disorders · 2025
DOI: 10.1186/s12872-024-04461-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift BMC Cardiovascular Disorders, 2025. Verfasst von Ruqiang Yuan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044, China. Hauptthemen laut MEDLINE: Angiotensin II, Molecular Docking Simulation, Hypertension, Disease Models, Animal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: The dried root of Inula helenium L., known as Inulae Radix in Mongolian medicine, is a widely used heat-clearing plant drug within the Asteraceae family. Alantolactone (ATL), a compound derived from Inulae Radix, is a sesquiterpene lactone with a range of biological activities. However, there is a lack of studies investigating its effectiveness in the treatment of hypertension. The aim of this study is to explore the regulatory effect of alantolactone on blood pressure and its underlying mechanism. METHODS AND RESULTS: Network pharmacology analysis suggested that ATL had a potential therapeutic effect on hypertension induced by angiotensin II (Ang II). Subsequently, the results of animal experiments demonstrated that ATL could suppress the increase in blood pressure caused by Ang II. Vascular ring experiments indicated that ATL could inhibit the vascular contractions induced by Ang II, Phenylephrine, and Ca2⁺. Further experiments demonstrated that ATL could inhibit the calcium influx induced by Ang II and increase the expression of pMLC2. Molecular docking experiments showed that ATL had a high binding affinity with L-type Voltage-gated Calcium Channels (VGCC), and vascular ring experiments indicated that ATL could significantly inhibit the vascular contractions caused by the agonists of L-type VGCC. In addition, we also observed that ATL had an ameliorative effect on the vascular remodeling induced by Ang II. CONCLUSIONS: ATL exerted an antihypertensive effect by inhibiting the activation of L-type VGCC and reducing calcium influx.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Advanced Institute for Medical Sciences, Dalian Medical University, Dalian, 116044, China.
- Department of Pharmacy, Dalian Port Hospital, Dalian, 116001, China.
- College of Pharmacy, Dalian Medical University, Dalian, 116044, China.
- Wuhu Hospital and Health Science Center, East China Normal University, Shanghai, 200241, China.
- College of Pharmacy, Dalian Medical University, Dalian, 116044, China. houlizh@163.com.
- Department of Pathology, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200080, China. qiangerjiao@126.com.
Zitieren
APA
Yuan, R., Gao, M., Xu, H., Liang, Q., Qian, L., Wang, Y., Zhang, H., Qiang, E., & Yun, W. (2025). Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-024-04461-2
Vancouver
Yuan R, Gao M, Xu H, Liang Q, Qian L, Wang Y, et al. Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation. BMC Cardiovascular Disorders. 2025. doi:10.1186/s12872-024-04461-2
BibTeX
@article{Yuan2025,
author = {Yuan, Ruqiang and Gao, Mingjing and Xu, Hu and Liang, Qing and Qian, Lei and Wang, Yali and Zhang, Houli and Qiang, Erjiao and Yun, Weijing},
title = {Alantolactone mitigates the elevation of blood pressure in mice induced by angiotensin II by inhibiting calcium channel activation},
journal = {BMC Cardiovascular Disorders},
year = {2025},
doi = {10.1186/s12872-024-04461-2}
}
EUVIMED